Hemorrhoidal disease is a common and often debilitating condition affecting millions of people in the United States. Traditionally, hemorrhoids have been treated through invasive surgical procedures ...
How do we take on and resolve vein-related pelvic pain in women? PeVD has been associated with venous-origin chronic pelvic ...
Embolization continues to be one of the most dynamic and rapidly evolving areas in endovascular care, with expanding indications, novel devices, a ...
Limb-lengthening can add inches to a person’s stature. But its risks have made it controversial. Credit... Supported by By Isabella Kwai Photographs by Matthew Leifheit Isabella Kwai spoke to ...
Rutgers Health experts have expanded treatment options for knee osteoarthritis, a condition caused by the gradual breakdown of knee cartilage because of obesity, injuries, genetics or aging, often ...
ABSTRACT: We present the case of an 82-year-old woman with progressive dyspnea, hoarseness, and dysphagia due to a large substernal multinodular goiter. Ultrasound and CT revealed a predominantly left ...
There was no correlation between inlet flow rate and EEI. Instead, EEI exhibited an inverse linear relationship with target pressure, declining until flow cessation at a certain pressure greater than ...
Dr. Garcia used the polymer-based coil to treat the patient's painful pelvic varices and chronic pelvic pain of venous origin, previously referred to pelvic congestion syndrome A woman in Delaware has ...
Tribune Online on MSN

Enlarged prostate and surgery

Kindly let me know if an enlarged Prostate can be managed without surgery or not.Nicholas (by SMS)Non-surgical options for reducing an enlarged prostate include lifestyle changes, medications, and ...
The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
A significant decrease was seen in serum levels of vascular endothelial growth factor and interleukin-1 receptor antagonist at 12 months. Bedros Taslakian, M.D., from the NYU Grossman School of ...